Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 638.32% | -54.41% | -14.47% | 1,123.57% | -81.91% |
| Total Receivables | -19.06% | -11.56% | -30.68% | -22.37% | 38.37% |
| Inventory | -5.51% | -3.70% | 76.43% | 1,880.00% | 0.00% |
| Prepaid Expenses | 118.45% | -46.80% | 76.61% | -85.74% | 82.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 160.41% | -28.10% | 1.38% | 51.87% | 5.28% |
|
|
|||||
| Total Current Assets | 160.41% | -28.10% | 1.38% | 51.87% | 5.28% |
| Net Property, Plant & Equipment | -- | -- | -50.00% | -33.33% | -25.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -4.64% | -3.93% | 2.44% | 1.25% | 3.49% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 44.26% | -12.65% | 2.04% | 15.14% | 3.95% |
|
|
|||||
| Total Accounts Payable | 36.35% | -51.86% | 1.66% | -23.20% | 28.44% |
| Total Accrued Expenses | -64.20% | -23.81% | 57.14% | -71.40% | -5.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -3.37% | 15.93% | 6.73% | -13.57% | 40.94% |
| Total Other Current Liabilities | -3.37% | 15.93% | 6.73% | -13.57% | 40.94% |
| Total Current Liabilities | 8.77% | -23.84% | 4.91% | -22.78% | 29.63% |
|
|
|||||
| Total Current Liabilities | 8.77% | -23.84% | 4.91% | -22.78% | 29.63% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.77% | -23.84% | 4.91% | -22.78% | 29.63% |
|
|
|||||
| Common Stock & APIC | 13.17% | 2.22% | 2.71% | 13.41% | 1.01% |
| Retained Earnings | -11.56% | -5.63% | -5.90% | -8.99% | -5.44% |
| Treasury Stock & Other | 213.29% | -3.69% | 44.84% | -- | -- |
| Total Common Equity | 57.78% | -7.46% | 0.77% | 47.27% | -10.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 57.78% | -7.46% | 0.77% | 47.27% | -10.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 57.78% | -7.46% | 0.77% | 47.27% | -10.99% |
|
|
|||||